EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Next-generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis

Nazifa Javaid, Nutan Tyagi, Akansha Misra, Rezhat Abbas, Meghanand T. Nayak

Current Trends in Dentistry · 2025

DOI: 10.4103/ctd.ctd_1_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Trends in Dentistry, 2025. Verfasst von Nazifa Javaid und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The second-most common blood cancer, multiple myeloma (MM), is characterized by abnormal proliferation and an accumulation of malignant plasma cells in the bone marrow. While the markers currently used in MM diagnosis and assessment are showing promising results, the disease’s incidence and mortality rate remain high, so there is a global interest in exploring and developing better diagnostic or prognostic biomarkers. In this review, we highlight some of the recently reported and investigated novel biomarkers that have great potential as diagnostic and/or prognostic tools in MM, including angiogenic markers, microRNAs (miRNAs), proteomic and immunological biomarkers, and some of the advanced methodologies that could be used in the early detection of MM. This review highlights recently investigated novel biomarkers with significant potential, including angiogenic markers, miRNAs, and proteomic and immunological biomarkers. In addition, we discuss advanced methodologies, such as next-generation sequencing and liquid biopsies, for early detection of MM. These emerging biomarkers and techniques represent a promising step toward improving patient outcomes through earlier diagnosis and personalized treatment strategies.

Zitieren

APA

Javaid, N., Tyagi, N., Misra, A., Abbas, R., & Nayak, M. T. (2025). Next-generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis. Current Trends in Dentistry. https://doi.org/10.4103/ctd.ctd_1_25

Vancouver

Javaid N, Tyagi N, Misra A, Abbas R, Nayak MT. Next-generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis. Current Trends in Dentistry. 2025. doi:10.4103/ctd.ctd_1_25

BibTeX
@article{Javaid2025,
  author = {Javaid, Nazifa and Tyagi, Nutan and Misra, Akansha and Abbas, Rezhat and Nayak, Meghanand T.},
  title = {Next-generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis},
  journal = {Current Trends in Dentistry},
  year = {2025},
  doi = {10.4103/ctd.ctd_1_25}
}
Kostenlos starten →